Follistatin-344

What is Follistatin-344?

Follistatin is a glycoprotein the body makes naturally. It binds and blocks several growth signals, most importantly myostatin, a protein that limits muscle growth, and activins, which act on reproduction, muscle and many other tissues. Follistatin was first studied in reproductive biology, where it got its name from its ability to suppress follicle-stimulating hormone, and was later found to matter for muscle.⁷

Follistatin-344 (FS-344) is the 344-amino acid precursor form of the protein. The body processes it into shorter forms, including one that circulates in the blood and one that stays bound to tissue surfaces. FS-344 is also the gene version used in animal and early human gene therapy research.

Online, follistatin-344 is sold as an injectable research chemical for muscle growth. It is not approved as a medicine anywhere, and it is banned in sport.

How Follistatin-344 works

Think of myostatin as a brake on muscle growth. Animals born without working myostatin, from lab mice to some cattle and dog breeds, carry far more muscle than normal. Follistatin grabs myostatin and activins before they can reach their receptors, which releases that brake. In periods of low food intake, follistatin appears to help the body hold on to lean mass by blocking signals that break muscle down.⁷

In more detail, myostatin and the activins belong to the TGF-beta family and signal through activin type II receptors and the Smad2 and Smad3 pathway to slow muscle protein building and promote breakdown. Follistatin binds these ligands tightly and blocks receptor access. It also binds some related proteins, so its effects are not limited to muscle. The activin, follistatin and inhibin axis is being studied in energy-deficiency states in athletes, though its role there is still not well understood.¹ A different protein with a similar name, follistatin-like 1, acts as a signaling molecule in fat tissue and should not be confused with follistatin.⁴

What the research shows on Follistatin-344

The dramatic results come from genetics, not from injections. Mice engineered to overproduce follistatin, or treated with gene therapy that delivers the FS-344 gene into muscle, develop much larger muscles. These models work because the muscle keeps making follistatin continuously.

In humans, the main data come from a small, early-phase gene therapy study in Becker muscular dystrophy, in which the FS-344 gene was injected into thigh muscles using a viral carrier. Some participants walked farther afterward. That was a one-time genetic treatment in a specific disease, not a test of injected follistatin protein, and it has not led to an approved therapy.

There are no published controlled trials showing that injecting follistatin protein builds muscle in people. The injected protein is cleared from the blood quickly, and there is no evidence it reaches muscle at useful levels for long enough to matter.

What the references here do show is that exercise raises the body's own follistatin. In a 16-week randomized trial in 22 older women with sarcopenia, resistance training increased blood follistatin and improved strength, gait speed and function, while other growth factors did not change.² In a 12-week trial in 21 older adults with sarcopenia, both low-load training with blood-flow restriction and conventional heavy training raised follistatin and improved strength.³ Whole-body vibration and resistance training both raised follistatin in a third small trial of 27 older adults.⁸ These studies show that training moves this pathway naturally; they do not show that follistatin causes the gains.

Drug developers have largely moved to antibodies that block activin and myostatin signaling, such as bimagrumab, trevogrumab and garetosmab. These are being studied, alone or with GLP-1-type drugs, to preserve muscle during weight loss.⁷

Studied for: Muscle hypertrophy research, Muscular dystrophy gene therapy research.

Follistatin-344 reference data

Follistatin-344 dosage in published research

Open this in the dosage calculator ↗

How Follistatin-344 is used in practice

Follistatin-344 is sold by research-chemical vendors, typically as 1 mg vials of freeze-dried powder, and injected under the skin or into muscle in short cycles. It is not offered through legitimate compounding pharmacies and is not prescribed in mainstream practice.

Authenticity is a particular concern here. Follistatin is a large, sugar-coated protein that has to be made in living cells, not a short peptide that can be assembled cheaply by chemical synthesis. Producing real, correctly folded protein at the prices charged online is difficult, so many products may contain little or no active follistatin.

Athletes should know that myostatin-blocking agents, including follistatin, are prohibited by the World Anti-Doping Agency.

A few people have gone further and sought follistatin gene therapy at clinics outside the US. That carries far greater unknowns than injecting the protein, because a gene therapy cannot simply be stopped if problems appear, and none of these offerings has been tested in a proper trial for healthy adults.

Follistatin-344 risks and side effects

Human safety data for injected follistatin protein essentially do not exist. Users report injection-site reactions and headaches, but the true side effect profile is unknown.

There are theoretical concerns. Follistatin and activins act in reproductive tissues, and altered levels of these factors appear in conditions such as endometriosis,⁵ so blocking activins could affect menstrual function or fertility. Because follistatin also binds other growth signals, effects outside muscle are possible. People with active cancer or who are pregnant should avoid it.

Product risks may matter most. Poorly made recombinant proteins can carry bacterial endotoxins and other impurities that cause fever or immune reactions, and unlabeled substitutes are possible.

Reported side effects

Alternatives to Follistatin-344

For building or keeping muscle, progressive resistance training is the best-supported option at any age, and the trials above show it also raises natural follistatin.² Adequate daily protein and creatine monohydrate have solid evidence for adding to training gains.

For people losing weight on GLP-1-type medicines, resistance training and enough protein help limit muscle loss, a concern highlighted in recent reviews.⁷ Medical causes of muscle loss, such as low testosterone, thyroid disease or chronic illness, should be diagnosed and treated directly. Muscle-preserving antibodies remain investigational and are available only in clinical trials.

Questions for a clinician

• What evidence applies to my situation, and at what level?
• What established alternatives should I consider first?
• What monitoring would be necessary, and how often?
• Can this be prescribed at all where I live, or only sold for research?